Artgen Biotech PJSC (MOEX:ISKJ)
Russia · Delayed Price · Currency is RUB 59.54
+0.84 (1.43%)
At close: Jul 8, 2022
Artgen Biotech PJSC Cash Flow Statement
Financials in millions RUB. Fiscal year is January - December.
Millions RUB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 246.93 | 214.91 | 168.86 | 46.12 | 11.63 | 72.85 | Upgrade |
Depreciation & Amortization | 109.6 | 84.35 | 70.9 | 53.48 | 79.84 | 72.39 | Upgrade |
Other Amortization | 0.36 | 0.36 | - | - | 1.44 | 2.5 | Upgrade |
Loss (Gain) From Sale of Assets | 0.11 | -0.52 | 0.58 | 75.31 | 26.51 | -41.74 | Upgrade |
Loss (Gain) on Equity Investments | 13.41 | 3.5 | 24.17 | -23.14 | 5.21 | 0.37 | Upgrade |
Provision & Write-off of Bad Debts | 8.36 | 11.98 | 13.43 | 15.41 | 12.73 | 52.37 | Upgrade |
Other Operating Activities | 186.22 | 234.66 | 112.13 | 84.91 | 99.99 | 112.27 | Upgrade |
Change in Accounts Receivable | -63.01 | -28.52 | -92.46 | 86.7 | 8.72 | -118.1 | Upgrade |
Change in Inventory | -10.82 | -21.58 | -1.51 | 16.4 | -21.54 | -106.02 | Upgrade |
Change in Accounts Payable | -108.25 | -17.32 | 138.75 | -134.9 | 56.27 | 6.98 | Upgrade |
Operating Cash Flow | 382.91 | 481.83 | 434.85 | 220.3 | 280.8 | 53.86 | Upgrade |
Operating Cash Flow Growth | -22.71% | 10.80% | 97.39% | -21.55% | 421.32% | -70.58% | Upgrade |
Capital Expenditures | -72.42 | -99.68 | -204.29 | -135.93 | -153.3 | -85.6 | Upgrade |
Cash Acquisitions | -13.21 | -4.88 | - | -78.96 | - | -70.25 | Upgrade |
Investment in Securities | -16.3 | -0.17 | -46.86 | -66.1 | -71.49 | 84.76 | Upgrade |
Other Investing Activities | 56.84 | 52.55 | 27.04 | 5.48 | 6.12 | -2.57 | Upgrade |
Investing Cash Flow | -218.53 | -171.31 | -216.97 | -346.78 | -252.25 | -79.16 | Upgrade |
Long-Term Debt Issued | - | - | - | 196 | 319.23 | 145 | Upgrade |
Long-Term Debt Repaid | - | -122.78 | -83.76 | -14.19 | -194.64 | -92.46 | Upgrade |
Net Debt Issued (Repaid) | -129.07 | -122.78 | -83.76 | 181.81 | 124.59 | 52.54 | Upgrade |
Issuance of Common Stock | 38.97 | - | 38.89 | 43.8 | 3.49 | 4.02 | Upgrade |
Repurchase of Common Stock | -35.96 | -35.96 | - | - | - | - | Upgrade |
Common Dividends Paid | -35.66 | -140.69 | -104.23 | - | - | - | Upgrade |
Other Financing Activities | -28.05 | -47.31 | 274.03 | -87.3 | -69.11 | -11.44 | Upgrade |
Financing Cash Flow | -189.77 | -346.74 | 124.94 | 138.31 | 58.96 | 45.12 | Upgrade |
Foreign Exchange Rate Adjustments | -0.25 | -5.38 | 0.46 | -3.46 | -1.61 | -2.18 | Upgrade |
Miscellaneous Cash Flow Adjustments | -0 | - | - | 0 | - | - | Upgrade |
Net Cash Flow | -25.64 | -41.59 | 343.28 | 8.37 | 85.9 | 17.65 | Upgrade |
Free Cash Flow | 310.48 | 382.16 | 230.56 | 84.37 | 127.51 | -31.74 | Upgrade |
Free Cash Flow Growth | 4.21% | 65.75% | 173.26% | -33.83% | - | - | Upgrade |
Free Cash Flow Margin | 19.22% | 25.12% | 16.85% | 7.42% | 10.80% | -2.93% | Upgrade |
Free Cash Flow Per Share | 3.33 | 4.13 | 2.49 | 0.97 | 1.59 | -0.42 | Upgrade |
Cash Interest Paid | 91.35 | 91.35 | 52.1 | 48.6 | 50.71 | 27.15 | Upgrade |
Cash Income Tax Paid | 5.8 | 5.8 | 24.64 | 3.83 | 5.71 | - | Upgrade |
Levered Free Cash Flow | 39.58 | 158.46 | -28.18 | -139.31 | -12.27 | -21.61 | Upgrade |
Unlevered Free Cash Flow | 90.57 | 217.87 | 2.59 | -96.92 | 19.4 | 3.49 | Upgrade |
Change in Working Capital | -182.08 | -67.42 | 44.78 | -31.79 | 43.46 | -217.14 | Upgrade |
Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.